76. STEMCELL INNOVATIONS: www.stemcellinnovations.com

Stem Cell Innovations (SCI) intends to become the global leader in human cell based drug discovery & development. SCI has laboratories and offices in Scotch Plains, N.J., Houston, TX and in Leiden, the Netherlands. SCI's core technology focuses on developing, growing, and manipulating human cells in the laboratory using proprietary technology. By growing pure cultures of individual cell types, SCI is currently developing a broad array of human primary cell models as powerful research tools that can form the basis of therapeutic breakthroughs. SCI has established several human pluripotent stem cell lines from fetal gonadal tissue using defined conditions. These PluriCellTM lines have been established directly onto tissue culture plastic without the use of feeder layers or conditioned medium. In addition to the PluriCell technology SCI has already established in vitro hepatocyte screening, kits, compositions, and services for compound toxicity testing, ACTIVTox® and PREDICTIVToxTM.